Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Rate Control Agents in Atrial Fibrillation
NCT01655303Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol, metoprolol, verapamil, diltiazem in Atrial fibrillation (AFib), sponsored by Tehran University of Medical Sciences. Started Feb 2011; status: completed.
02
Drugs
propranololmetoprololverapamildiltiazem
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01655303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655303.